Video

How do you prioritize the genomic information provided by NGS and how do you curate the importance of alterations, rearrangements, and fusion events reported by NGS? (Korean)

Name: How do you prioritize the genomic information provided by NGS and how do you curate the importance of alterations, rearrangements, and fusion events reported by NGS? (Korean)
Uploaded: 2017-09-25T00:00:00+00:00
Description: How do you prioritize the genomic information provided by NGS and how do you curate the importance of alterations, rearrangements, and fusion events reported by NGS?

Published: September 25, 2017

How do you prioritize the genomic information provided by NGS and how do you curate the importance of alterations, rearrangements, and fusion events reported by NGS? (Korean)

How do you prioritize the genomic information provided by NGS and how do you curate the importance of alterations, rearrangements, and fusion events reported by NGS?

Overview

CLICK HERE FOR CME CREDIT

Created by

Presenter

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea

Related Videos

Video

What have we learned from the recent trials looking at the ability of NGS to drive precision-based treatments across a broad spectrum of tumor subtypes? (Korean)

What have we learned from the recent trials looking at the ability of NGS to drive precision-based treatments across a broad spectrum of tumor subtypes?

Video

What specific information, variances, actionable guidance, and clinical/biological interpretations are provided on a NGS pathology report? How do you apply an NGS report clinically? (Korean)

What specific information, variances, actionable guidance, and clinical/biological interpretations are provided on a NGS pathology report? How do you apply an NGS report clinically?

Video

What is the evidence that personalized, gene-directed therapy, in which molecular drivers identified by NGS produce treatments that are better aligned with actionable targets, will improve outcomes?

What is the evidence that more personalized, gene-directed cancer therapy, in which specific molecular drivers identified by NGS will produce treatments that are better aligned with actionable targets and will improve patient outcomes?

Video

In South Korea, how is NGS playing an increasingly important role in the Yonsei Cancer Center in the genomic profiling of cancer and to guide selection of oncology treatment? (Korean)

In South Korea, how is NGS playing an increasingly important role in the Yonsei Cancer Center in the genomic profiling of cancer and to guide selection of oncology treatment?